You need JavaScript to view this

The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake

Abstract

The labeling of cells with fluorescent nanoparticles is promising for various biomedical applications. The objective of this study is to evaluate the biocompatibility and the mechanism of the cellular uptake of fluorescent nanodiamonds (FNDs) in cancer cells (HeLa) and pre-adipocytes (3T3-L1). With flow cytometry and the use of a battery of metabolic and cytoskeletal inhibitors, we found that the mechanism of the FND uptake in both cells is by energy-dependent clathrin-mediated endocytosis. In addition, the surface charge of FND influences its cellular uptake, as the uptake of poly-L-lysine-coated FNDs is better than that of oxidative-acid-purified FNDs at the same concentration in regular medium with or without serum. We also confirm that the proliferative potential of FND-treated and untreated cells does not exhibit any significant differences when measured at bulk cultures, and more stringently at clonal cell density. Further biocompatibility studies indicate that the in vitro differentiation of 3T3-L1 pre-adipocytes and 489-2 osteoprogenitors is not affected by the FND treatment. Our results show that FNDs are biocompatible and ideal candidates for potential applications in human stem cell research.
Authors:
Vaijayanthimala, Vairakkannu; Tzeng, Yan-Kai; Chang, Huan-Cheng; [1]  Li, Chung-Leung [2] 
  1. Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei 106, Taiwan (China)
  2. Genomics Research Center, Academia Sinica, Taipei 115, Taiwan (China)
Publication Date:
Oct 21, 2009
Product Type:
Journal Article
Resource Relation:
Journal Name: Nanotechnology (Print); Journal Volume: 20; Journal Issue: 42; Other Information: DOI: 10.1088/0957-4484/20/42/425103; PII: S0957-4484(09)20488-0
Subject:
77 NANOSCIENCE AND NANOTECHNOLOGY; FLUORESCENCE; IN VITRO; LABELLING; LYSINE; NANOSTRUCTURES; NEOPLASMS; OXIDATION; STEM CELLS; SURFACES; UPTAKE; AMINO ACIDS; ANIMAL CELLS; CARBOXYLIC ACIDS; CHEMICAL REACTIONS; DISEASES; EMISSION; LUMINESCENCE; ORGANIC ACIDS; ORGANIC COMPOUNDS; PHOTON EMISSION; SOMATIC CELLS
OSTI ID:
21489523
Country of Origin:
United Kingdom
Language:
English
Other Identifying Numbers:
Journal ID: ISSN 0957-4484; TRN: GB10P1440080710
Availability:
Available from http://dx.doi.org/10.1088/0957-4484/20/42/425103
Submitting Site:
GBN
Size:
9 pages
Announcement Date:
Oct 27, 2011

Citation Formats

Vaijayanthimala, Vairakkannu, Tzeng, Yan-Kai, Chang, Huan-Cheng, and Li, Chung-Leung. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. United Kingdom: N. p., 2009. Web. doi:10.1088/0957-4484/20/42/425103.
Vaijayanthimala, Vairakkannu, Tzeng, Yan-Kai, Chang, Huan-Cheng, & Li, Chung-Leung. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. United Kingdom. https://doi.org/10.1088/0957-4484/20/42/425103
Vaijayanthimala, Vairakkannu, Tzeng, Yan-Kai, Chang, Huan-Cheng, and Li, Chung-Leung. 2009. "The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake." United Kingdom. https://doi.org/10.1088/0957-4484/20/42/425103.
@misc{etde_21489523,
title = {The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake}
author = {Vaijayanthimala, Vairakkannu, Tzeng, Yan-Kai, Chang, Huan-Cheng, and Li, Chung-Leung}
abstractNote = {The labeling of cells with fluorescent nanoparticles is promising for various biomedical applications. The objective of this study is to evaluate the biocompatibility and the mechanism of the cellular uptake of fluorescent nanodiamonds (FNDs) in cancer cells (HeLa) and pre-adipocytes (3T3-L1). With flow cytometry and the use of a battery of metabolic and cytoskeletal inhibitors, we found that the mechanism of the FND uptake in both cells is by energy-dependent clathrin-mediated endocytosis. In addition, the surface charge of FND influences its cellular uptake, as the uptake of poly-L-lysine-coated FNDs is better than that of oxidative-acid-purified FNDs at the same concentration in regular medium with or without serum. We also confirm that the proliferative potential of FND-treated and untreated cells does not exhibit any significant differences when measured at bulk cultures, and more stringently at clonal cell density. Further biocompatibility studies indicate that the in vitro differentiation of 3T3-L1 pre-adipocytes and 489-2 osteoprogenitors is not affected by the FND treatment. Our results show that FNDs are biocompatible and ideal candidates for potential applications in human stem cell research.}
doi = {10.1088/0957-4484/20/42/425103}
journal = []
issue = {42}
volume = {20}
place = {United Kingdom}
year = {2009}
month = {Oct}
}